About this document
FCVM 09 892335 by Hernández Bustamante Miriam Esther is a document available to read on EtoBox.
The document discusses the etiology and management of dyslipidemia in cancer patients, highlighting the increased cardiovascular disease (CVD) risk associated with lipid abnormalities due to cancer and its treatments. It emphasizes the need for personalized cardiovascular assessments and management strategies for cancer survivors, as traditional CVD risk tools may underestimate their risk. The review also explores the impact of various anticancer therapies on lipid levels and the potential role of statins a
- Author
- Hernández Bustamante Miriam Esther
- Language
- EN